Skip to main content
. 2021 May 20;16(5):e0241454. doi: 10.1371/journal.pone.0241454

Table 6. Univariate association with recurrence-free survival.

Variables N RFS
HR (95%CI) P-value Log-rank P-value
Sex Male 10 2.98 (0.50–56.65) 0.26 0.29
Female 6 Ref.
Age >65 years 7 1.21 (0.23–5.61) 0.81 0.81
<65 years 9 Ref.
Stage IV 3 11.43 (1.09–247.04) 0.04 0.01
I–III 13 Ref.
Postoperative chemotherapy Done 10 1.74 (0.38–12.22) 0.49 0.50
None 6 Ref.
IHC dMMR 8 0.69 (0.14–3.13) 0.62 0.62
pMMR 8 Ref.
TMB <10 mut/Mb 3 2.97 (0.41–15.37) 0.25 0.18
≥10 mut/Mb 13 Ref.
SMAD4 Mutation 5 4.15 (0.90–21.41) 0.07 0.04
Wild 11 Ref.

IHC: immunohistochemical, TMB: tumor mutational burden, mut/MB: mutations per megabase of DNA, MMR: mismatch repair, dMMR: deficient mismatch repair, pMMR: proficient mismatch repair, HR: hazard ratio, RFS: recurrence-free survival.